Frank Tegtmeier
Algemeen Directeur bij vasopharm GmbH
Oorsprong van het eerstegraads netwerk van Frank Tegtmeier
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
vasopharm GmbH
vasopharm GmbH Pharmaceuticals: MajorHealth Technology vasopharm GmbH operates as a pharmaceutical company. It discovers and develops novel therapeutics for the treatment of cerebro and cardiovascular diseases and their consequences. The firm focuses on therapeutics influencing the bioavailability of nitric oxide. The company was founded by Harald Schmidt and Ulrich Walter in July 1998 and is headquartered in Wuerzburg, Germany.
8
| Holding Company | Pharmaceuticals: Major | 8 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Frank Tegtmeier via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
Lundbeck Research USA, Inc.
Lundbeck Research USA, Inc. Pharmaceuticals: MajorHealth Technology Lundbeck Research USA, Inc. develops pharmaceutical products and information to the medical community. The firm engages in the drug discovery aimed at treating central nervous system diseases by designing small molecule therapeutics. The company was founded in 1990 and is headquartered in Paramus, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
HENKEL AG & CO. KGAA | Household/Personal Care | Corporate Officer/Principal | |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal | |
PAION AG | Pharmaceuticals: Major | Director/Board Member | |
4SC AG | Biotechnology | Director/Board Member | |
CEVEC Pharmaceuticals GmbH
CEVEC Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology CEVEC Pharmaceuticals GmbH engages in the manufacture of biopharmaceuticals using a human cell-based expression system. It provides therapeutic proteins and monoclonal antibodies. The company was founded by Stefan Kochanek in 2004 and is headquartered in Cologne, Germany. | Pharmaceuticals: Major | Director/Board Member | |
OCEAN WILSONS HOLDINGS LIMITED | Marine Shipping | Director/Board Member | |
Future Capital
Future Capital Investment ManagersFinance Future Capital (Future Capital) is an independent venture capital firm which was founded in 1999 as the initiative of the Hessen State Government and Hoechst AG (now Sanofi-Aventis Group). The firm is headquartered in Frankfurt, Germany. | Investment Managers | Chief Executive Officer | |
The University of Edinburgh | College/University | Doctorate Degree | |
Technische Universität München | College/University | Undergraduate Degree | |
University of Bocconi | College/University | Undergraduate Degree | |
University of Siegen | College/University | Doctorate Degree | |
London Business School | College/University | Masters Business Admin | |
Ludwig-Maximilians-Universität München | College/University | Masters Business Admin | |
Creathor Venture Management GmbH
Creathor Venture Management GmbH Investment ManagersFinance Creathor Venture Management GmbH is an independent private equity firm specialized in technology venture capital investing. Creathor was foundedi n 2003 and is headquartered in Bad Homburg near Frankfurt in central Germany. The management invests their own capital, and manages venture capital funds on behalf of institutions. | Investment Managers | Private Equity Investor | |
3i Private Equity
3i Private Equity Investment ManagersFinance 3i Private Equity is a private equity firm, founded in 1945. The firm is headquartered in London, United Kingdom with additional offices around the world. | Investment Managers | Private Equity Investor | |
Algenex SL
Algenex SL BiotechnologyHealth Technology Algenex SL develops and manufactures recombinant proteins. It specializes in the baculovirus vector-based innovative technologies to manufacture recombinant proteins used to produce vaccines, diagnostic reagents and therapeutic molecules. The company was founded by Jose Angel Martinez Escribano and Covadonga Alonso on January 19, 2005 and is headquartered in Pozuelo de Alarcon, Spain. | Biotechnology | Chief Executive Officer | |
Reabourne Ltd. | Founder | ||
Julius-Maximilians-Universität Würzburg | College/University | Undergraduate Degree Corporate Officer/Principal | |
Max Planck Institute of Biochemistry | College/University | Doctorate Degree | |
CHDI Foundation, Inc. | Chief Tech/Sci/R&D Officer | ||
HAML Consulting GmbH | Chief Investment Officer | ||
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin | |
BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Pharmaceuticals: Major | Director/Board Member | |
Peterhouse College Cambridge | College/University | Graduate Degree | |
Ocean Wilsons (Investments) Ltd. | Director/Board Member | ||
Wave Life Sciences USA, Inc.
Wave Life Sciences USA, Inc. Electric UtilitiesUtilities Part of Wave Life Sciences Ltd., Wave Life Sciences USA, Inc. is a company that provides nucleic acid therapeutics. The company is based in Cambridge, MA. The company was founded in 2012 by Gregory L. Verdine, Takeshi Wada. The CEO is Paul B. Bolno. | Electric Utilities | Corporate Officer/Principal | |
Blueprint Genetics Oy
Blueprint Genetics Oy BiotechnologyHealth Technology Blueprint Genetics Oy engages in the provision of genetic diagnostics and clinical interpretation of hereditary diseases. It offer dignistic tests for cardiology; dermatology; endocrinology; immunology; metabolic disorder; nephrology; and pulmonology. The company was founded by Tommi Pietari Lehtonen, Juha Koskenvuo, Tero-Pekka Alastalo, and Samuel Myllykangas in 2008 and is headquartered in Helsinki, Finland. | Biotechnology | Director/Board Member | |
Fort Rock Capital Ltd.
Fort Rock Capital Ltd. Financial ConglomeratesFinance Fort Rock Capital Ltd. provides investment services. The company is headquartered in London, the United Kingdom. | Financial Conglomerates | Director/Board Member | |
Coller Capital Ltd. (Hong Kong) | Investment Managers | Corporate Officer/Principal | |
Medinet Midco I Ltd.
Medinet Midco I Ltd. Medical/Nursing ServicesHealth Services Part of Medinet Topco Ltd., Medinet Midco I Ltd. is a provider of specialised clinical teams that deliver additional elective services to the NHS. The company is based in Sutton Coldfield, UK. Medinet Midco I offers urology and dermatology insourcing services, as well as fully managed specialised clinical teams. The British company was founded in 2016 and has been helping to reduce NHS waiting times for 15 years. | Medical/Nursing Services | Director/Board Member | |
Medinet Bidco Ltd. | Miscellaneous | Director/Board Member | |
Cleon Capital Advisors SL
Cleon Capital Advisors SL Investment ManagersFinance Cleon Capital Advisors SL (Cleon Capital Advisors) is a private equity firm founded in 2015 by Nicola Zambon. The firm is headquartered in Madrid, Spain with additional office in Milan. | Investment Managers | Consultant / Advisor | |
Hansa Capital GmbH
Hansa Capital GmbH Financial ConglomeratesFinance Part of Hanseatic Asset Management LBG, Hansa Capital GmbH is a Swiss company that provides investment services. The company is based in Pfäffikon, Switzerland. | Financial Conglomerates | Chief Investment Officer | |
Greenhill & Co. Spain Ltd.
Greenhill & Co. Spain Ltd. Investment ManagersFinance Part of Greenhill & Co., Inc., Greenhill & Co. Spain Ltd. is a Spanish company that provides financial advisory services. The company is based in Madrid, Spain. | Investment Managers | Private Equity Investor | |
Medinet Clinical Services Ltd.
Medinet Clinical Services Ltd. Medical/Nursing ServicesHealth Services Part of Medinet Topco Ltd., Medinet Clinical Services Ltd. is a leading provider of specialised clinical teams delivering additional elective services to the NHS. The company is based in Sutton Coldfield, UK. The British company offers fully managed specialised clinical teams to help reduce NHS waiting times throughout the UK, including urology and general surgery insourcing. The company was founded in 2005 with the intention of easing the pressure on the NHS service, so that it can see and treat more patients. | Medical/Nursing Services | Director/Board Member | |
Medinet Midco II Ltd.
Medinet Midco II Ltd. Financial ConglomeratesFinance Part of Medinet Topco Ltd., Medinet Midco II Ltd. functions as an investment holding British company. The company is based in Sutton Coldfield, UK and was founded in 2016. | Financial Conglomerates | Director/Board Member | |
GAIN THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
WILSON SONS S.A. | Other Transportation | Director/Board Member | |
BIOHAVEN LTD. | Pharmaceuticals: Major | Director/Board Member | |
New Biohaven Pharmaceuticals, Inc. | Director/Board Member | ||
EveryONE Medicines, Inc.
EveryONE Medicines, Inc. Miscellaneous Commercial ServicesCommercial Services EveryONE Medicines, Inc. delivers individualized precision therapeutics customized to the unique pathogenic genetic mutation of patients. EveryONE Medicines is based in Boston, MA. The company's goal is to provide quality of life to patients by slowing or even halting their disease. The company was founded by Julia Vitarello and Keith Flanagan. The CEO is Nessan Bermingham. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
Pregimmune Corp.
Pregimmune Corp. Medical/Nursing ServicesHealth Services Pregimmune Corp. is a private company based in Dover, DE. The company specializes in developing novel immunotherapies for pregnancy-related complications. The company's research focuses on understanding the immune system's role in pregnancy and developing therapies to prevent or treat complications such as preeclampsia, preterm birth, and fetal growth restriction. | Medical/Nursing Services | Director/Board Member |
Statistieken
Internationaal
Verenigde Staten | 15 |
Duitsland | 13 |
Verenigd Koninkrijk | 11 |
Bermuda | 4 |
Spanje | 4 |
Sectoraal
Consumer Services | 11 |
Health Technology | 11 |
Finance | 10 |
Health Services | 5 |
Transportation | 4 |
Operationeel
Director/Board Member | 29 |
Corporate Officer/Principal | 13 |
Chief Tech/Sci/R&D Officer | 6 |
Doctorate Degree | 5 |
Private Equity Investor | 4 |
Sterkste connecties
- Beurs
- Insiders
- Frank Tegtmeier
- Bedrijfsconnecties